除了用药物控制术后随之而来的感染，患者还接受了四种药物的联合治疗，以期减轻免疫反应，从而降低排斥反应发生的可能性。
In addition to drugs to prevent subsequent infection, the patient was administered a combination of four drugs to help mitigate the immune response and thus decrease chances of rejection.
结论：赛尼哌用于肾移植的免疫诱导治疗，可以预防和减少急性排斥反应的发生，安全性和耐受性好。
CONCLUSION: Zenapax used for immunity induction of renal transplantation can prevent and reduce the occurrence of acute reject reaction, it has safety and good tolerance.
结论异种移植发生延迟性排斥反应时，P选择素和ICAM - 1均有表达，可以作为判断异种移植免疫抑制治疗效果的指标之一。
Conclusion the expression of P-selectin and ICAM-1 in xenografts was increased during delayed xenograft rejection, which is of value in judging the effect of immunosuppression in xenotransplantation.
结论HCV感染可抑制肾移植患者的细胞免疫功能，但不影响患者感染及急性排斥反应的发生率。
Conclusions HCV infection can suppress host cell immune function, but doesn't affect the rates of acute rejections and infections.
结果患者无免疫排斥反应，未发生与骨移植相关的并发症。
Results No obvious immune rejection response and complications related to cortical strut allograft were found in the patients.
目的论述异种移植排斥反应的发生机制和各种免疫细胞的相互作用。
Objective To investigate the mechanism of xenotransplantation rejection and the interaction between the immunocytes.
目的论述异种移植排斥反应的发生机制和各种免疫细胞的相互作用。
Objective To investigate the mechanism of xenotransplantation rejection and the interaction between the immunocytes.
应用推荐